/Companies

Elira Therapeutics

St. Louis, US · Founded 2015 · Delaware corporation

Find your way into Elira Therapeutics

Sign up to see every warm intro you have to Elira Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Elira Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

BJ
Bevil J HoggExecutive
LJ
Luis J. MalaveExecutive

Board

RE
Raul E. PerezBoard director
PV
Paul V. GoodeBoard director

Reported raises · per SEC filings

Form D private placements

$14M disclosed across 9 rounds · 2015–2023

▶$3.4MraisedJun 2024 · 34 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • C. David AdairDirector
  • Jason A. DarrahExecutive Officer
  • A. Travis SpitzerDirector
  • Raul E. PerezExecutive Officer, Director
  • Arda M. MinocherhomjeeDirector
Offering amount
$4.7M
Amount sold
$3.4M
Minimum investment
$400
First sale
Sep 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedDec 2022 · 19 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • A. Travis SpitzerDirector
  • Jason A. DarrahExecutive Officer
  • Charlie BoltenDirector
  • Arda M. MinocherhomjeeDirector
  • C. David AdairDirector
  • Raul E. PerezExecutive Officer, Director
Offering amount
$3.5M
Amount sold
$1.3M
Minimum investment
$1K
First sale
Dec 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.6MraisedJan 2021 · 24 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • C. David AdairDirector
  • Jason A. DarrahExecutive Officer
  • Charlie BoltenDirector
  • A. Travis SpitzerDirector
  • Raul E. PerezExecutive Officer, Director
  • Arda M. MinocherhomjeeDirector
Offering amount
$3.2M
Amount sold
$1.6M
Minimum investment
$1K
First sale
Dec 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$973.7KraisedNov 2019 · 20 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Bankim H MehtaExecutive Officer, Director
  • Charlie BoltenDirector
  • Danika R. HarrisonDirector
  • A. Travis SpitzerDirector
  • Derek H. LeeDirector
  • Arda M. MinocherhomjeeDirector
  • Jason A. DarrahExecutive Officer
  • Ralph G. Dacey, Jr.Director
  • Bevil J. HoggDirector
  • Raul E. PerezDirector
Offering amount
$2M
Amount sold
$973.7K
Minimum investment
$25K
First sale
Oct 2019
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$912.7KraisedMar 2019 · 38 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Arda M. MinocherhomjeeDirector
  • Bevil J. HoggDirector
  • Ralph G. Dacey, Jr.Director
  • Jason A. DarrahExecutive Officer
  • Derek H. LeeDirector
  • Raul E. PerezDirector
  • Charles BoltenDirector
  • Danika R. HarrisonExecutive Officer, Director
  • A. Travis SpitzerDirector
Offering amount
$2M
Amount sold
$912.7K
First sale
Feb 2019
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$923.1KraisedAug 2018 · 25 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • A. Travis SpitzerDirector
  • Steven A. EdmundowiczExecutive Officer
  • Bevil J. HoggDirector
  • Charles BoltenDirector
  • Jason A. DarrahExecutive Officer
  • Derek H. LeeDirector
  • Danika R. HarrisonExecutive Officer, Director
  • Ralph G. Dacey, Jr.Director
  • Arda M. MinocherhomjeeDirector
  • Raul E. PerezDirector
Offering amount
$923.1K
Amount sold
$923.1K
First sale
Aug 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.9MraisedDec 2017 · 33 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Danika R. HarrisonExecutive Officer, Director
  • Raul E. PerezDirector
  • Arda M. MinocherhomjeeDirector
  • Bevil J. HoggDirector
  • Ralph G. Dacey, Jr.Director
  • Jason A. DarrahExecutive Officer
  • Steven A. EdmundowiczExecutive Officer
  • A. Travis SpitzerDirector
  • Charles BoltenDirector
  • Derek H. LeeDirector
Offering amount
$2.5M
Amount sold
$1.9M
Minimum investment
$50K
First sale
Dec 2017
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.9MraisedDec 2016 · 21 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Bevil J. HoggDirector
  • Raul E. PerezDirector
  • Derek H. LeeDirector
  • Luis J. MalaveExecutive Officer
  • Ralph G. DaceyDirector
  • A. Travis SpitzerDirector
  • Arda M. MinocherhomjeeDirector
  • Jason A. DarrahExecutive Officer
Offering amount
$5M
Amount sold
$1.9M
Minimum investment
$50K
First sale
Nov 2016
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Elira Therapeutics raised?
Elira Therapeutics has disclosed $14M raised across 9 rounds.
Where is Elira Therapeutics headquartered?
Elira Therapeutics is headquartered in St. Louis, US.